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Abstract
Metalloendoprotease activity was identified in retinal homogenates using a synthetic fluorogenic metalloen- 
doprotease substrate and specific metalloendoprotease inhibitors. The requirement of metalloendoprotease 
activity in neurotransmitter release was examined during the depolarization-induced release of [3H]glycine 
from the retina of Xenopus laeuis. Neurons with high affinity uptake and calcium-dependent, K+-stimulated 
release of glycine have been described previously in this retina. When isolated retinas preloaded with [3H] 
glycine are depolarized by 22 mM K+, the usual efflux of [3H] glycine is completely abolished by the metalloen­
doprotease inhibitor, 1,10-phenanthroline (100 /xg/ml). The inhibition of [3H]glycine release by 1,10-phenan- 
throline is dose dependent; furthermore, 1,10-phenanthroline blocks release by chelating metal and not Ca2+, 
since addition of equimolar calcium does not alter the inhibition. The metalloendoprotease inhibitor, carbo- 
benzoxy (CBZ)-L-phenylalanine, also prevents release, whereas the amino acid, L -pheny la lan ine , has no effect. 
Synthetic carbobenzoxy dipeptide amides which are metalloendoprotease substrates (e.g., CBZ-Gly-Leu-amide, 
CBZ-Ser-Leu-amide, and CBZ-Gly-Phe-amide) also prevent [3H]glycine release in a dose-dependent and 
reversible manner. The synthetic dipeptide CBZ-Gly-Gly-amide, however, is not a metalloendoprotease sub­
strate and has no effect on release. The ability of synthetic dipeptides to inhibit neurotransmitter release is 
amino acid specific, dose dependent, reversible, and matches their ability to interact with characterized 
metalloendoproteases. Depolarization-stimulated transmitter release may therefore require the activity of a 
metalloendoprotease.
Neurotransmitter release is achieved through the fusion of 
synaptic vesicles with the presynaptic membrane resulting in 
the liberation of vesicle contents into the extracellular space. 
Neuronal depolarization, either by the action potential or by 
increasing the extracellular K+ concentration, causes a tran­
sient influx of calcium into the presynaptic terminal and initi­
ates the fusion of synaptic vesicles with the plasma membrane 
(Kelly et al., 1983). Neurotransmitter release thus involves 
calcium-dependent membrane fusion. The biochemical mech­
anisms regulating calcium-dependent membrane fusion are in­
completely understood but are probably responsible for regu­
lating the timing, extent, and site of fusion.
Metalloendoproteases are metal-dependent proteolytic en­
zymes which hydrolyze certain peptide bonds distant from the 
ends of polypeptide chains (Barrett, 1977). Activity of endoge­
nous metalloendoproteases has been proposed as a requirement 
for calcium-dependent membrane fusion in the fusion of mono­
nucleate myoblasts to form multinucleated myotubes (Couch
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and Strittmatter, 1983) and in neurotransmitter release at the 
neuromuscular junction (Baxter et al., 1983). Electrophysio- 
logic examination of the neuromuscular junction did not di­
rectly demonstrate presynaptic inhibition of neurotransmitter 
release by metalloendoprotease inhibitors, and biochemical me­
talloendoprotease assays could not be performed on the syn­
aptic terminal. Consequently, we are examining the possibility 
in the retina that metalloendoprotease activity within the pre­
synaptic terminal may be required for neurotransmitter release.
A population of retinal neurons in Xenopus laevis accumu­
lates [ ’H] glycine by high affinity uptake and releases accumu­
lated glycine in response to elevated K+ in the extracellular 
medium (Rayborn et al., 1981). The isolated retina preparation 
has several advantages as a model system for studying the 
requirement of metalloendoprotease activity during neuro­
transmitter release. The glycine-accumulating neurons are in­
tact, unlike brain slice or synaptosome preparations, and [3H] 
glycine release can be directly and quantitatively assayed. The 
depolarization-induced release of retinal glycine is calcium 
dependent (Rayborn et al., 1981). Finally, metalloendoprotease 
activity can be identified and characterized in the retina.
Materials and Methods
Autoradiographic demonstration of high affinity uptake of [3H]glycine 
by retinal neurons. Juvenile and adult toads, Xenopus laeuis, were 
obtained from Nasco (Ft. Atkinson, WI) and Carolina Biological Supply3112
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Figure 1. Localization of [3H]glycine uptake by retinal neurons in Xenopus laevis. Photomicrographs were taken of retinas incubated for 15 
min with 2 /iM [3H]glycine before processing for autoradiography. Heavily labeled neurons are present in the inner nuclear layer (arrows). The 
two micrographs, showing the same retinal area, are photographed with transmitted (upper) and darkfield (lower) illumination. ONL, outer 
nuclear layer, INL, inner nuclear layer; GC, ganglion cell layer.
Co. (Burlington, NC). The animals were dark-adapted overnight prior 
to dissection. After removing the anterior segment, each retina was 
isolated from its vitreous humor and pigment epithelium in minimal 
essential medium at 5°C (Frederick et al., 1982).
The autoradiographic methods have been described (Hollyfield et 
al., 1979). Briefly, isolated retinas were incubated with 2 txM [3H]glycine
for 15 min, rinsed in fresh medium, transferred through the serial 
changes of media of a release experiment (see below), fixed overnight 
in 2% glutaraldehyde/1% formaldehyde in 100 m M  Sorenson’s phos­
phate buffer (pH 7.35), postfixed for 30 min in 1% osmium tetroxide 
in the same buffer, and embedded in Epon. After polymerization, 1- 
/jm-thick sections were cut, coated with Kodak NTB2 liquid emulsion,
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and exposed for 6 hr to 3 days. The autoradiograms were developed, 
stained, and examined with transm itted and darkfield microscopy to 
identify the cells which localize [3H]glycine.
Determination of [3H]glycine release. Twenty retinas were trans­
ferred by pipette to a 1.5-ml conical centrifuge tube for incubation for 
15 min in 200 jul of medium containing 20 f i d  of [3H]glycine (specific 
activity, 44 Ci/mmol, New England Nuclear, Boston, MA; 2 /iM final 
concentration). The retinas were washed in three 5-ml changes of fresh 
medium (10 min each) with gentle agitation and were washed for an 
additional two 10-min intervals with either fresh medium or medium 
containing 1,10-phenanthroline. Fresh medium containing the carbo- 
benzoxy (CBZ) dipeptide amides was added 6 min before depolarization. 
Groups of four retinas were transferred every 3 min to 2 ml of either 
normal medium or isotonic K+-rich medium in which 19 m M  KC1 had 
been substituted for NaCl, for a final KC1 concentration of 22 mM . 
Incubation in 22 m M  K+ buffer is indicated by the bar on the abscissa 
of each figure. One milliliter of incubation medium was mixed with 10 
ml of scintillant (ACS), and the radioactivity was measured by a liquid 
scintillation counter (Packard Tri-Carb). The retinas were homoge­
nized in 1 ml of medium and mixed with scintillant, and the radioac­
tivity was determined. Release of [3H]glycine into the media was 
calculated as a percentage of disintegrations per minute of [3H]glycine 
released into the medium following each incubation to the disintegra­
tions per minute of [3H] glycine remaining in the tissue a t the corre­
sponding sample time. All dipeptide derivatives were obtained from 
Vega Biochemicals (Phoenix, AZ), and 1,10-phenanthroline was ob­
tained from Sigma Chemical Co (St. Louis, MO).
High voltage paper electrophoresis was used to estimate the per­
centage of radioactivity released into the media by depolarization which 
was free [3H]glycine. Aliquots of 22 m M  K+ buffer from release exper­
iments were brought to dryness in a concentrator (Savant) and recon­
stituted with carrier solution (5 mg/ml of glycine, 5 mg/ml of choline 
chloride in 0.1 N HC1). Ten microliters of sample were spotted on paper 
for electrophoresis. After separation, glycine was identified with nin- 
hydrin as described by Hildebrand et al. (1971) and eluted, and the 
radioactivity was measured.
Biochemical characterization of metalloendoprotease. The fluorescent 
protease substrate, 2-aminobenzoyl-alanine-glycine-leucine-alanine-4- 
nitrobenzylamide (AAGLAN), and the active site inhibitor, 2-{N- 
hydroxycarboxamide)-4-methylpentanoyl-L-Ala-Gly-amide, were syn­
thesized by D. Rasnick (Enzyme Systems Products, Livermore, CA). 
Metalloendoprotease activity was characterized in the cytoplasmic and 
pellet fractions of homogenized retinas. Forty retinas from dark- 
adapted, adult Xenopus were isolated and suspended in 3.5 ml of 150 
mM KC1 in 10 mM HEPES, pH 7.3, a t 5°C. The retinas were homoge­
nized with 15 strokes in a glass-glass homogenizer. The homogenate 
was then centrifuged at 100,000 X g for 2 hr; the supernatant and pellet 
were collected and frozen at —80°C until used.
Metalloendoprotease activity was assayed in 50 1 of the supernatant 
containing a total of 50 fig of protein, in a final volume of 150 /al of 150 
m M  KC1, 10 m M  HEPES, pH 7.3. The final concentration of AAGLAN 
was 0.3 m M  in 2% dimethylformamide. After incubation a t 37°C for 5 
to 8 hr, the hydrolyzed substrate was measured spectrofluorometrically 
(Aminco Bowman Model SPF-500) with an excitation wavelength of 
340 nm and an emission wavelength of 415 nm. The amount of substrate 
hydrolyzed was calculated by comparison with a standard curve estab­
lished by complete hydrolysis of AAGLAN (0 to 1.0 m M ) with 2 Mg/ml 
of thermolysin. The results are the mean of duplicate incubations and 
are expressed as nanomoles of AAGLAN hydrolyzed per milligram of 
protein per hour of incubation.
R esults
Identification of high-affinity p'H]glycine uptake in retinal 
neurons. To localize and identify neurons which have high 
affinity uptake for glycine, isolated retinas were incubated with
2 pM [3H]glycine and processed for autoradiography. As seen 
in Figure 1, [:!H]glycine is accumulated by perikarya of the 
inner nuclear layer. Silver grains also appear scattered through­
out the inner and outer synaptic layers. Ultrastructural studies 
(Rayborn et al., 1981) have shown [3H]glycine accumulation of 
the inner and outer plexiform layers within bulbous terminals 
having pre- and postsynaptic densities and synaptic vesicles. 
[3H]Glycine is taken up with high affinity by a population of 
retinal neurons, and not glia.
Demonstration of Ca2+-dependent, depolarization-induced 
release of pH]glycine. Neurons which demonstrate high affinity 
uptake of [3H]glycine will release [3H]glycine when depolarized 
in media containing 22 mM K+. Figure 2 shows efflux of [3H] 
glycine from retinas depolarized three times in succession (Fig. 
2, solid bars on abscissa). However, 3 mM CoCl2 in the medium 
blocks calcium influx and prevents depolarization-induced ef­
flux (Fig. 2, middle bar labeled K + and Co2+). The release 
appears to be calcium dependent. High voltage paper electro­
phoresis of media collected during K+-stimulated efflux reveals 
that >50% of the released radioactivity co-migrates with free 
glycine. In Xenopus, certain retinal neurons show specific, high 
affinity uptake of glycine and release of accumulated glycine in 
response to depolarizing stimuli.
Demonstration that metalloendoprotease inhibitors prevent 
depolarization-induced release of the neurotransmitter, glycine.
1,10-Phenanthroline is a metal chelator which inactivates me- 
talloproteases and has a high critical stability constant for
Figure 2. K+-stimulated release of [3H]gly- 
cine from retinal neurons. After preloading with 
[3H]glycine, retinas were transferred a t 3-min 
intervals through incubation media of either 
normal (3 m M ) or high (22 m M , solid bars) K+. 
The incubation solutions were collected and 
monitored for radioactivity. Large amounts of 
label were released following the first ^ - d e ­
polarization, whereas simultaneous incubation 
with 22 m M  K+ and 3 m M  Co2+ caused no efflux 
of radioactivity above base line levels. After 
removing Coz+, K+-depolarization again caused 
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metals and a low constant for calcium (for Zn2+ K  = 2 X 106 m; 
for Ca2+ K  = 5 m) (Smith and Martell, 1975). When added to 
the medium after retinas were loaded with [3H]glycine, 1,10- 
phenanthroline blocked the depolarization-induced release of 
[3H]glycine (Fig. 3). To demonstrate that 1,10-phenanthroline 
inhibited release by chelating metal and not calcium, excess 
calcium equimolar to 1,10-phenanthroline was added, and 
release was still blocked (Fig. 3). The inhibition of release by
1,10-phenanthroline was dose dependent (Fig. 4). The concen­
tration of 1,10-phenanthroline required to block release com­
pletely (100 fig/ml) is the same concentration required to com­
pletely inhibit the retinal metalloendoprotease (see Fig. 10). 
CBZ-L-Phenylalanine is a reversible inhibitor of metalloendo- 
proteases (Burstein et al., 1974). CBZ-L-Phenylalanine pre-
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Figure 3. Inhibition of K+-stimulated release of [3H]glycine by 1,10- 
phenanthroline. Retinas preloaded with [3H]glycine were incubated for 
20 min in either 1% dimethylsulfoxide (DMSO) (O), 1,10-phenanthro­
line (200 Mg/ml, 1.1 mM) in 1% DMSO (• ) , or 1,10-phenanthroline 
with equimolar CaCl2 (A). The retinas were then transferred at 3-min 
intervals to incubation media with normal or 22 mM K+ (solid bars); 
released radioactivity was later measured in the incubation solutions. 
Retinas incubated in 1,10-phenanthroline with DMSO fail to release 
[3H]glycine in response to K+-depolarization, whereas retinas incubated 
in DMSO alone release large amounts of radioactivity. Addition of Ca2+ 
equimolar with 1,10-phenanthroline, in addition to the normal Ca2+ 
composition of the medium, does not prevent the inhibition of [3H] 
glycine release.
T i m e  ( m i n )
Figure 4. Concentration-dependent inhibition by 1,10-phenanthro- 
line of [3H]glycine release in response to K+-depolarization. Retinas 
preloaded with [3H]glycine were incubated with phenanthroline at 
various concentrations for 20 min before transfer to successive changes 
of media at 3-min intervals. Aliquots of media were counted for released 
radioactivity. Note the progressive reduction in the amount of radio­
activity released with increasing phenanthroline concentrations.
vented [3H]glycine release in a dose-dependent manner, 
whereas L-phenylalanine, which has no effect on metalloendo­
protease activity, had no effect on neurotransmitter release 
(Fig. 5). . . .
Metalloendoproteases will hydrolyze CBZ dipeptide amides 
only if the derivative contains a peptide bond hydrolyzed by 
this protease. Metalloendoproteases hydrolyze CBZ-Gly-Leu- 
amide, CBZ-Ser-Leu-amide, and CBZ-Gly-Phe-amide, but not 
CBZ-Gly-Gly-amide (Morihara, 1974). We tested these dipep­
tides for their effects on the depolarization-induced release of 
glycine, to determine whether their ability to block neurotran- 
sitter release paralleled the ability to interact with metalloen­
doproteases. The dipeptide CBZ-Gly-Phe-amide, which is a 
metalloendoprotease substrate, blocked depolarization-induced 
glycine release, whereas CBZ-Gly-Gly-amide, which is not me­
talloendoprotease substrate, had no effect (Figs. 6 and 7, top). 
The inhibition of [3H] glycine release by CBZ-Gly-Phe-amide 
was reversible (Fig. 6). CBZ-Gly-Phe-amide blocked release in 
a dose-dependent fashion (Fig. 7). The dipeptide metalloendo­
protease substrates CBZ-Gly-Leu-amide and CBZ-Ser-Leu- 
amide similarly blocked depolarization-induced [3H]glycine 
release (not shown). Hence, inhibition of neurotransmitter





? 'Figure 5. Specificity of a CBZ-amino acid inhibition -J_ 
of [3H]glycine release. Retinas preloaded with [3H] « 
glycine were preincubated with CBZ-L-phenylalanine Ll 
or L-phenylalanine for 12 min before K+-depolariza- O  3 
tion. The K+-Stimulated efflux of radioactivity was x  
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Figure 6. Specificity and reversibility of CBZ-dipeptide amides as inhibitors of K+-stimulated [3H]glycine release. Retinas preloaded with [3H] 
glycine were transferred at 3-min intervals to media with normal or 22 m M  K+ (solid bars). The first and third K+ depolarizations were performed 
under identical conditions and involved neither dipeptide substrates nor dimethylsulfoxide. Between times t = 21 and t = 33 min, either 1% 
dimethylsulfoxide (A), 1.5 m M  CBZ-Gly-Gly-amide in dimethylsulfoxide (O), or 1.5 m M  CBZ-Gly-Phe-amide in dimethylsulfoxide ( • )  were 
introduced into the media. CBZ-Gly-Phe-amide inhibited [3H]glycine efflux during the second K+ pulse; inhibition was completely reversed after 
removing CBZ-Gly-Phe-amide. In contrast, neither CBZ-Gly-Gly-amide nor dimethylsulfoxide had any effect on the efflux of radioactivity in 
response to K+ stimulation. 3116
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Figure 7. Specificity and dose-de­
pendent inhibition by CBZ-dipeptide 
amides of K+-stimulated [3H]glycine 
release. Retinas preloaded with [3H] 
glycine were incubated with either 
CBZ-Gly-Phe-amide (left) or CBZ- 
Gly-Gly-amide (right). The ^ - s t i m ­
ulated efflux of [3H]glycine was re­
duced with increasing concentrations 
of CBZ-Gly-Phe-amide and was un­
altered at any concentration of CBZ- 
Gly-Gly-amide.
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release by synthetic metalloendoprotease substrate is amino 
acid specific, dose dependent, and reversible.
Identification and characterization of retinal metalloendopro­
tease. Assay of metalloendoprotease activity is based on hy­
drolysis of AAGLAN, a sensitive and specific fluorogenic syn­
thetic protease substrate developed by Kam et al. (1979). AAG­
LAN contains the Gly-Leu bond hydrolyzed by metalloendo­
proteases. Hydrolysis of the peptide bond frees the fluorescent 
2-aminobenzoyl group from intramolecular quenching by the 
4-nitrobenzylamide. Fluorescence therefore quantitatively re­
flects the amount of substrate hydrolyzed.
The Xenopus retina contains soluble and membrane-associ­
ated metalloendoprotease activities which hydrolyze this fluo­
rogenic metalloendoprotease substrate. Hydrolysis of AAGLAN 
by the soluble metalloendoprotease was linear for at least 8 hr 
(Fig. 8), was saturable with an apparent K m of approximately 
0.5 mM (Fig. 9), and was inhibited by the metal chelator 1,10- 
phenanthroline with an ICso of approximately 20 /ig/ml (Fig. 
10). An active site metalloendoprotease inhibitor, 2-(Ar-hydrox- 
ycarboxamide) -4-methylpentanoyl-L-Ala-Gly-amide (Nishino 
and Powers, 1979), also inhibited the protease with an Ic50 of 
approximately 5 ^M. Metalloendoprotease activity is found in 
both the cytoplasmic and pellet fractions of retinal homoge- 
nates. We do not know whether metalloendoprotease activity 
found in the pellet fraction is the same enzyme identified in 
the soluble fraction which is simply associated with the mem­
branes, trapped in vesicles, or alternatively, a different metal­
loendoprotease. Studies are in progress to determine whether 
the soluble and membrane-associated retinal metalloendopro­
teases have different inhibitor specificities. Soluble (Orlowski 
et al., 1983) and membrane-associated (Orlowski and Wilk, 
1981; Benuck et al., 1982; Matsas et al., 1983) metalloendopro­
teases have been documented extensively in brain.
Discussion
Metalloendoproteases are a class of soluble or membrane- 
bound proteases which are identified and characterized by 
specific inhibitors. Zinc, present in the native enzyme, is re­
quired for catalytic activity, although other metals may also 
confer proteolytic activity to the apoenzyme (Chlebowski and 
Coleman, 1976). The metal chelator, 1,10-phenanthroline, is a 
potent metalloendoprotease inhibitor and has received exten­
sive use in studies of metalloendoproteases (Barrett, 1977).
In retinal homogenates we have demonstrated protease ac­
tivity which hydrolyzes the fluorogenic metaloendoprotease 
substrate, AAGLAN, and which is inhibited by 1,10-phenan- 
throline. Depolarization-induced release of [3H] glycine from 
retinal neurons in vitro is also inhibited by 1,10-phenanthro- 
line. The dose-response relationships of 1,10-phenanthroline 
inhibition of metalloendoprotease activity in retinal homoge­
nates and inhibition of [3H] glycine release from retinal neurons 
were virtually identical (for comparison, see Figs. 3 and 10).
1,10-Phenanthroline does not block neurotransmitter release






Figure 8. Hydrolysis of fluorogenic metalloendoprotease substrate, 
AAGLAN. Retinas were homogenized; the supernatant fraction was 
incubated for the times indicated with 0.3 m M  AAGLAN. The amount 
of AAGLAN hydrolyzed was then measured spectrofluorometrically 
and was expressed as nanomolar concentrations of AAGLAN hydro­
lyzed per milligram of protein. The rate of hydrolysis was linear during 
the 8-hr incubation.
AAGLAN [mM]
Figure 9. Saturation of soluble retinal metalloendoprotease by AAG­
LAN. The supernatant fraction of a retinal homogenate was incubated 
6 hrs with increasing concentrations (0-4 m M ) of AAGLAN. The 
amount of AAGLAN hydrolyzed was measured spectrofluorometrically. 
Hydrolysis of AAGLAN is saturable with an apparent Km of approxi­
mately 0.5 m M .
Figure 10. Inhibition of soluble retinal metalloendoprotease by 1,10- 
phenanthroline. Supernatant fractions of a retinal homogenate were 
incubated for 6  hr with 0.3 m M  AAGLAN and increasing concentrations 
(0 to 150 Mg/ml) of 1,10-phenanthroline. The hydrolysis of AAGLAN 
was inhibited by the metal chelator 1,10-phenanthroline with an IC50 
of approximately 20 fig/ml. The concentration of 1,10-phenanthroline 
which completely inhibited hydrolysis of AAGLAN was the same 
concentration a t which 1,10-phenanthroline inhibited K+-stimulated 
[3H]glycine release from retinal neurons (cf. Fig. 4).
by chelating calcium since excess calcium added to the retinal 
preparation does not restore neurotransmitter release. The 
reversible metalloendoprotease inhibitor, CBZ-L-phenylala­
nine, likewise inhibited [3H] glycine release at concentrations 
inhibiting metalloendoprotease (Burstein et al., 1974), whereas 
L-phenylalanine, which has no effect on metalloendoproteases, 
had no effect on release.
The substrate specificities of metalloendoproteases are sim­
ilar and have been examined extensively using synthetic dipep­
tide derivatives (Morihara, 1974; Barrett, 1977). Metalloendo­
proteases hydrolyze peptide bonds on the amino termini of 
nonpolar aromatic amino acids such as phenylalanine and large 
aliphatic amino acids such as leucine. They will not hydrolyze 
the peptide bonds formed by the small aliphatic amino acid, 
glycine. Metalloendoproteases thus hydrolyze the dipeptide 
substrates CBZ-Gly-Phe-amide, CBZ-Gly-Leu-amide, and 
CBZ-Ser-Leu-amide, but not CBZ-Gly-Gly-amide.
This paper presents evidence for the hypothesis that metal­
loendoproteases are involved in the release of transmitter sub­
stances at synapses. Our observations show that CBZ dipeptide 
amides, which are metalloendoprotease substrates, prevent [3H] 
glycine release whereas dipeptide derivatives, which are not 
metalloendoprotease substrates, have no effect. CBZ dipeptide- 
amides, which are able to enter cells (Grinde et al., 1983), 
inhibit [3H] glycine release, possibly by competing with the 
natural substrates of the metalloendoproteases. Inhibition of 
release by these dipeptide substrates is dose dependent, with 
concentrations causing half-maximal inhibition similar to the 
Km concentrations for metalloendoproteases (Morihara, 1974). 
In addition to being amino acid specific and concentration 
dependent, dipeptide inhibition of transmitter release was re-
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versible, since release could be restored by removing the dipep­
tide (Fig. 6).
Metalloendoprotease substrates and inhibitors prevent the 
depolarization-induced release of preload [3H]glycine from a 
population of retinal neurons, but the mechanism of this inhi­
bition is not understood. The inhibitors could alter the electri­
cal properties of the neuron, prevent calcium influx, or inhibit 
the mechanism by which calcium initiates synaptic vesicle- 
plasma membrane fusion. This study implicates metalloendo­
protease activity in neurotransmitter release from intact neu­
rons of CNS derivation. Another study using a phrenic nerve- 
diaphragm preparation has demonstrated that metalloendopro­
tease inhibitors block synaptic communication from the nerve 
to the muscle, apparently by blocking neurotransmitter release, 
since they cause no changes in resting potential, transmem­
brane resistance, or amplitude and configuration of the action 
potential evoked by direct electrical stimulation of the muscle 
(Baxter et al., 1983). We show that the retina contains metal­
loendoprotease and that metalloendoprotease inhibitors pre­
vent synaptic release of neurotransmitter.
The role of proteases in membrane fusion has been docu­
mented in viral-host cell fusion (Klenk et al., 1979). Both 
orthomyxovirus (influenza) and paramyxovirus (Sendai, New­
castle Disease virus) contain integral membrane protein re­
quired for fusion of the viral membrane with the host cell 
membrane. Viral coat protein is processed to convert the pre­
cursor protein, which cannot fuse, to a protein which can. 
Hemagglutinin, an integral membrane protein of influenza 
(Wilson et al., 1981), can mediate fusion only after cleavage of 
a single peptide bond to create two disulfide-linked fragments 
(HAi and HA2) (Klenk et al., 1975). The role of hemagglutinin 
in membrane fusion has been shown directly by inserting the 
cloned hemagglutinin gene into fibroblasts (White et al., 1982). 
These fibroblasts will synthesize the intact viral hemagglutin 
and insert the protein into the plasma membrane, but the cells 
will not fuse. Incubation of these cells with trypsin produces 
the HAi and HA2 fragments of hemagglutinin, mimicking in 
vivo proteolysis and causing cell-cell fusion. This and other 
experiments show that protein can facilitate membrane fusion 
and that “processing” of protein is necessary. That metallopro- 
tease inhibitors and substrates block the depolarization-in­
duced release of [3H]glycine from retinal neurons suggests that 
a similar proteolytic event may be required for fusion of the 
synaptic vesicle with the plasma membrane.
Inhibition of transmitter release by synthetic dipeptide me­
talloendoprotease substrates also suggests a mechanism by 
which endogenous neuropeptides could modulate release. The 
neuropeptide /3-endorphin, for example, has been shown to be 
hydrolyzed in brain to release the dipeptide glycyl-glutamine. 
Iontophoretic application of glycyl-glutamine depresses spon­
taneous firing of neurons in rat brain (Parish et al., 1983). 
Hydrolysis not only inactivates the neuropeptide /3-endorphin, 
but produces a dipeptide which itself inhibits neuronal activity, 
possibly by inhibiting a proteolytic event.
In summary, retinal homogenates contain metalloendopro­
tease activity. Inhibitors and synthetic dipeptide substrates for 
metalloendoprotease prevent the calcium-dependent release of 
neurotransmitter from retinal neurons with the same specificity 
and dose dependency as their interaction with the metalloen­
doprotease. Proteolysis by a metalloendoprotease therefore ap­
pears to be a required step in neurotransmitter release.
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